AgingResearch.News: Longevity-sovelluksen kuvake

The fastest way to know what really works in longevity

Tekijä: PAPERFOOT AI PTE. LTD. · Sosiaalinen media
Debuts-pisteet 76UusiAnna ensimmäinen arvio

Miksi odotamme sitä: Clear, well-documented value for longevity researchers, with evidence-focused descriptions and useful follow and alert features.

AgingResearch.News: Longevity, kuvakaappaus 1AgingResearch.News: Longevity, kuvakaappaus 2AgingResearch.News: Longevity, kuvakaappaus 3AgingResearch.News: Longevity, kuvakaappaus 4AgingResearch.News: Longevity, kuvakaappaus 5

Samankaltaiset Sosiaalinen media-sovellukset

Katso parhaat

Lyhyesti

AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.

Debutsin tekemä tiivistelmä App Store -listauksen pohjalta.

Lisää Sosiaalinen media-sovelluksia

Viikon parhaat uudet Sosiaalinen media-sovellukset

Tietoa

The fastest way to know what really works in longevity.

AgingResearch.News scans the world’s ageing research in real time: 1,800+ papers an hour from PubMed, bioRxiv, medRxiv, arXiv, Europe PMC and journals worldwide. It reads every one, weighs the evidence and tells you what it found in plain English, with every claim cited. Over 690,000 papers so far.

NEVER MISS A BREAKTHROUGH The papers that matter, ranked on evidence, never on fame. What was studied, in whom, what changed, and the catch, at a glance. Mouse, cell or human: you see it instantly.

FOLLOW WHAT YOU CARE ABOUT Follow a drug, gene, pathway, disease, lab or author, and get an alert the moment a new paper on it lands. Rapamycin, senolytics, NAD+, metformin, GLP-1s, epigenetic clocks, reprogramming: thousands of subjects, each with an evidence profile from cells and mice to human trials.

ASK THE LITERATURE Ask anything about ageing research and get an answer in seconds, drawn from the papers, with the sources to check.

SEE THE FIGURES Every paper’s own figures, a tap away. Save papers to read later, on your phone and on the web.

PLUS For you: your field, ranked for your own research, with a match score on every paper. 20 questions a day to Ask, 5 interests and 25 follows, each with its own alerts, and export to Zotero, EndNote or Mendeley. One subscription works in the app and on agingresearch.news.

PRO Everything in Plus, with 500 questions a day to Ask, 25 interests, unlimited follows and 10 email digests. On agingresearch.news: company profiles, asset records, dashboards, watchlists and the catalyst calendar, 25 Ultradeep reviews a day, due-diligence packs, and the API and MCP server.

Plus and Pro renew automatically unless cancelled at least 24 hours before the period ends. Manage or cancel them in your Apple Account settings.

Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Terms: https://agingresearch.news/terms Privacy: https://agingresearch.news/privacy

Kysymyksiä sovelluksesta AgingResearch.News: Longevity

Mikä AgingResearch.News: Longevity on?
AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.
Onko AgingResearch.News: Longevity ilmainen?
Kyllä. AgingResearch.News: Longevity on ilmainen ladata.
Millä laitteilla AgingResearch.News: Longevity toimii?
AgingResearch.News: Longevity toimii laitteilla: iPhone, iPad.
Millä kielillä AgingResearch.News: Longevity on saatavilla?
AgingResearch.News: Longevity on saatavilla 11 kielellä, muun muassa: saksa, englanti, espanja, ranska, italia, japani.
Kuka on kehittänyt sovelluksen AgingResearch.News: Longevity?
Sovelluksen AgingResearch.News: Longevity on kehittänyt PAPERFOOT AI PTE. LTD.. App Storen ikäraja on 12+.
Mitä vaihtoehtoja sovellukselle AgingResearch.News: Longevity on?
Samankaltaisia sovelluksia Debutsissa: Chaluu: Accessible Messaging, Vigia Brasília, Fanfold: News as Magazines.

Ihmisten arvio

Kirjaudu sisään arvioidaksesi tämän sovelluksen. Rehellisyys on tärkeintä.

Ei vielä arvioita. Oletko kokeillut sitä? Anna ensimmäinen arvio.

Löydettävyyssignaalit

Miten tekoäly ja ihmiset löytävät sovelluksen AgingResearch.News: Longevity Debutsissa
TekoälyvalmisOsittain
78 % kuvattu tekoälyn kohdennusta varten
Löydettävissä nytKäytössäRakenteinen data tällä sivulla ja Debuts API

Kerro, mistä pidät. Lähetämme sähköpostia vain, kun jokin uusi vastaa toiveitasi, ja kehittäjät lisäävät usein testaajille edun.

Millaisia sovelluksia
Laitteellani:
Näytä vain
Kuinka usein
Lähetämme vahvistuslinkin. Mitään ei tule, ennen kuin napsautat sitä.